Evidence map›Paper›PMID 25793885›Full record

ArticlePloS one2015

Calcium alginate gels as stem cell matrix-making paracrine stem cell activity available for enhanced healing after surgery.

Andreas Schmitt, Philipp Rödel, Cihad Anamur, Claudine Seeliger, Andreas B Imhoff, Elmar Herbst, Stephan Vogt, Martijn van Griensven, Gerhard Winter, Julia Engert

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Stem Cell Therapy for Burns: Story so Far.Biologics : targets & therapy · 2021
    Review
  8. Article
  9. Article
  10. Microfluidic fabrication of stable collagen microgels with aligned microstructure using flow-driven co-deposition and ionic gelation.Journal of micromechanics and microengineering : structures, devices, and systems · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Andreas SchmittDepartment of Sports Orthopedics, Technical University Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
Philipp RödelDepartment of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Butenandtstr. 5, Haus B, D-81377 Munich, Germany.
Cihad AnamurDepartment of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Butenandtstr. 5, Haus B, D-81377 Munich, Germany.
Claudine SeeligerDepartment of Trauma Surgery, Technical University Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
Andreas B ImhoffDepartment of Sports Orthopedics, Technical University Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
Elmar HerbstDepartment of Sports Orthopedics, Technical University Munich, Ismaninger Str. 22, D-81675 Munich, Germany; Department of Trauma Surgery, Medical University Innsbruck (MUI), Anichstr. 35, A-6020 Innsbruck, Austria.
Stephan VogtDepartment of Sports Orthopedics, Technical University Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
Martijn van GriensvenDepartment of Trauma Surgery, Technical University Munich, Ismaninger Str. 22, D-81675 Munich, Germany.
Gerhard WinterDepartment of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Butenandtstr. 5, Haus B, D-81377 Munich, Germany.
Julia EngertDepartment of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University Munich, Butenandtstr. 5, Haus B, D-81377 Munich, Germany.
Technical University of Munich · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regeneration after surgery can be improved by the administration of anabolic growth factors. However, to locally maintain these factors at the site of regeneration is problematic. The aim of this study was to develop a matrix system containing human mesenchymal stem cells (MSCs) which can be applied to the surgical site and allows the secretion of endogenous healing factors from the cells. Calcium alginate gels were prepared by a combination of internal and external gelation. The gelling behaviour, mechanical stability, surface adhesive properties and injectability of the gels were investigated. The permeability of the gels for growth factors was analysed using bovine serum albumin and lysozyme as model proteins. Human MSCs were isolated, cultivated and seeded into the alginate gels. Cell viability was determined by AlamarBlue assay and fluorescence microscopy. The release of human VEGF and bFGF from the cells was determined using an enzyme-linked immunoassay. Gels with sufficient mechanical properties were prepared which remained injectable through a syringe and solidified in a sufficient time frame after application. Surface adhesion was improved by the addition of polyethylene glycol 300,000 and hyaluronic acid. Humans MSCs remained viable for the duration of 6 weeks within the gels. Human VEGF and bFGF was found in quantifiable concentrations in cell culture supernatants of gels loaded with MSCs and incubated for a period of 6 weeks. This work shows that calcium alginate gels can function as immobilization matrices for human MSCs.

Indexed as

AlginatesAnimalsCalcium ChlorideCattleCell SurvivalGelsGlucuronic AcidHexuronic AcidsHumansHydrogel, Polyethylene Glycol DimethacrylateIntercellular Signaling Peptides and ProteinsMechanical PhenomenaMesenchymal Stem CellsMuramidaseParacrine CommunicationSerum Albumin, BovineAlginatesCalcium ChlorideGelsGlucuronic AcidHexuronic AcidsHydrogel, Polyethylene Glycol DimethacrylateIntercellular Signaling Peptides and ProteinsMuramidaseSerum Albumin, Bovine

Identifiers

PMID25793885
PMCPMC4368733
OpenAlexW2049170578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.